MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202617079132 A) filed by Katmai Pharmaceuticals, Inc. on June 26, 2026, for Compositions And Methods For Treating Cancer.
Inventors include Brail, Leslie Harris; Du, Edna; and Vecchio, Daniela.
The application for the patent was published on August 14, 2026, under issue no. 33/2026.
Abstract: The disclosure relates to methods of treating glioblastoma and other EGFR mediated cancers. For example, the disclosure related to methods of treating glioblastoma in a subject by administering a dose of Compound 1 between about 100 mg per day and about 260 mg per day.
Disclaimer: Curated by HT Syndication.
